Loading…
Mulitiple primary cancers in familes with Li-Fraumeni syndrome
BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue...
Saved in:
Published in: | JNCI : Journal of the National Cancer Institute 1998-04, Vol.90 (8), p.606 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 8 |
container_start_page | 606 |
container_title | JNCI : Journal of the National Cancer Institute |
container_volume | 90 |
creator | Hisada, Michie Garber, Judy E Fung, Claire Y Fraumeni, Joseph F Li, Frederick P |
description | BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers. |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_220977292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28694891</sourcerecordid><originalsourceid>FETCH-proquest_journals_2209772923</originalsourceid><addsrcrecordid>eNqNirsKwjAUQIMoWB__ENwDaaymXVzE4qCbewn1Fm9J0prbIP17O_gBnuUM58xYkmZHKVQqD3OWSKm0yHOdLdmKqJUThcoSdrpHiwP2Fngf0Jkw8tr4GgJx9LwxDi0Q_-Dw4jcUZTDRgUdOo3-GzsGGLRpjCbY_r9muvDzOV9GH7h2BhqrtYvBTqpSShdaqUPu_pi9Q7Dld</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220977292</pqid></control><display><type>article</type><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><source>Oxford Journals Online</source><creator>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</creator><creatorcontrib>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</creatorcontrib><description>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>Oxford: Oxford Publishing Limited (England)</publisher><subject>Cancer ; Genetics ; Medical research</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1998-04, Vol.90 (8), p.606</ispartof><rights>Copyright Superintendent of Documents Apr 15, 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Hisada, Michie</creatorcontrib><creatorcontrib>Garber, Judy E</creatorcontrib><creatorcontrib>Fung, Claire Y</creatorcontrib><creatorcontrib>Fraumeni, Joseph F</creatorcontrib><creatorcontrib>Li, Frederick P</creatorcontrib><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><title>JNCI : Journal of the National Cancer Institute</title><description>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</description><subject>Cancer</subject><subject>Genetics</subject><subject>Medical research</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNirsKwjAUQIMoWB__ENwDaaymXVzE4qCbewn1Fm9J0prbIP17O_gBnuUM58xYkmZHKVQqD3OWSKm0yHOdLdmKqJUThcoSdrpHiwP2Fngf0Jkw8tr4GgJx9LwxDi0Q_-Dw4jcUZTDRgUdOo3-GzsGGLRpjCbY_r9muvDzOV9GH7h2BhqrtYvBTqpSShdaqUPu_pi9Q7Dld</recordid><startdate>19980415</startdate><enddate>19980415</enddate><creator>Hisada, Michie</creator><creator>Garber, Judy E</creator><creator>Fung, Claire Y</creator><creator>Fraumeni, Joseph F</creator><creator>Li, Frederick P</creator><general>Oxford Publishing Limited (England)</general><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>19980415</creationdate><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><author>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2209772923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Cancer</topic><topic>Genetics</topic><topic>Medical research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hisada, Michie</creatorcontrib><creatorcontrib>Garber, Judy E</creatorcontrib><creatorcontrib>Fung, Claire Y</creatorcontrib><creatorcontrib>Fraumeni, Joseph F</creatorcontrib><creatorcontrib>Li, Frederick P</creatorcontrib><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hisada, Michie</au><au>Garber, Judy E</au><au>Fung, Claire Y</au><au>Fraumeni, Joseph F</au><au>Li, Frederick P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><date>1998-04-15</date><risdate>1998</risdate><volume>90</volume><issue>8</issue><spage>606</spage><pages>606-</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</abstract><cop>Oxford</cop><pub>Oxford Publishing Limited (England)</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8874 |
ispartof | JNCI : Journal of the National Cancer Institute, 1998-04, Vol.90 (8), p.606 |
issn | 0027-8874 1460-2105 |
language | eng |
recordid | cdi_proquest_journals_220977292 |
source | Oxford Journals Online |
subjects | Cancer Genetics Medical research |
title | Mulitiple primary cancers in familes with Li-Fraumeni syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A21%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mulitiple%20primary%20cancers%20in%20familes%20with%20Li-Fraumeni%20syndrome&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Hisada,%20Michie&rft.date=1998-04-15&rft.volume=90&rft.issue=8&rft.spage=606&rft.pages=606-&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/&rft_dat=%3Cproquest%3E28694891%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_2209772923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=220977292&rft_id=info:pmid/&rfr_iscdi=true |